Cargando…

A Novel Case of Bifacial Diplegia Variant of Guillain-Barré Syndrome Following Janssen COVID-19 Vaccination

Guillain-Barré syndrome (GBS) is an immune-mediated demyelinating disorder which attacks the peripheral nervous system. Antecedent infection or vaccine administration are known to precipitate the onset of this disorder. Its typical presentation leads to a symmetric, rapidly progressive, ascending pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Prasad, Apoorv, Hurlburt, Gage, Podury, Sanjiti, Tandon, Medha, Kingree, Seth, Sriwastava, Shitiz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395825/
https://www.ncbi.nlm.nih.gov/pubmed/34449715
http://dx.doi.org/10.3390/neurolint13030040
_version_ 1783744258381971456
author Prasad, Apoorv
Hurlburt, Gage
Podury, Sanjiti
Tandon, Medha
Kingree, Seth
Sriwastava, Shitiz
author_facet Prasad, Apoorv
Hurlburt, Gage
Podury, Sanjiti
Tandon, Medha
Kingree, Seth
Sriwastava, Shitiz
author_sort Prasad, Apoorv
collection PubMed
description Guillain-Barré syndrome (GBS) is an immune-mediated demyelinating disorder which attacks the peripheral nervous system. Antecedent infection or vaccine administration are known to precipitate the onset of this disorder. Its typical presentation leads to a symmetric, rapidly progressive, ascending paresis with associated sensory deficits and impaired reflexes. We present a rare case of a bi-facial diplegia variant of GBS, within four weeks of the COVID-19 vaccination. Due to its chronology, clinical manifestations, and cerebrospinal fluid (CSF) findings, we propose this case to be a rare complication of the COVID-19 vaccination.
format Online
Article
Text
id pubmed-8395825
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-83958252021-08-28 A Novel Case of Bifacial Diplegia Variant of Guillain-Barré Syndrome Following Janssen COVID-19 Vaccination Prasad, Apoorv Hurlburt, Gage Podury, Sanjiti Tandon, Medha Kingree, Seth Sriwastava, Shitiz Neurol Int Interesting Images Guillain-Barré syndrome (GBS) is an immune-mediated demyelinating disorder which attacks the peripheral nervous system. Antecedent infection or vaccine administration are known to precipitate the onset of this disorder. Its typical presentation leads to a symmetric, rapidly progressive, ascending paresis with associated sensory deficits and impaired reflexes. We present a rare case of a bi-facial diplegia variant of GBS, within four weeks of the COVID-19 vaccination. Due to its chronology, clinical manifestations, and cerebrospinal fluid (CSF) findings, we propose this case to be a rare complication of the COVID-19 vaccination. MDPI 2021-08-13 /pmc/articles/PMC8395825/ /pubmed/34449715 http://dx.doi.org/10.3390/neurolint13030040 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Interesting Images
Prasad, Apoorv
Hurlburt, Gage
Podury, Sanjiti
Tandon, Medha
Kingree, Seth
Sriwastava, Shitiz
A Novel Case of Bifacial Diplegia Variant of Guillain-Barré Syndrome Following Janssen COVID-19 Vaccination
title A Novel Case of Bifacial Diplegia Variant of Guillain-Barré Syndrome Following Janssen COVID-19 Vaccination
title_full A Novel Case of Bifacial Diplegia Variant of Guillain-Barré Syndrome Following Janssen COVID-19 Vaccination
title_fullStr A Novel Case of Bifacial Diplegia Variant of Guillain-Barré Syndrome Following Janssen COVID-19 Vaccination
title_full_unstemmed A Novel Case of Bifacial Diplegia Variant of Guillain-Barré Syndrome Following Janssen COVID-19 Vaccination
title_short A Novel Case of Bifacial Diplegia Variant of Guillain-Barré Syndrome Following Janssen COVID-19 Vaccination
title_sort novel case of bifacial diplegia variant of guillain-barré syndrome following janssen covid-19 vaccination
topic Interesting Images
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8395825/
https://www.ncbi.nlm.nih.gov/pubmed/34449715
http://dx.doi.org/10.3390/neurolint13030040
work_keys_str_mv AT prasadapoorv anovelcaseofbifacialdiplegiavariantofguillainbarresyndromefollowingjanssencovid19vaccination
AT hurlburtgage anovelcaseofbifacialdiplegiavariantofguillainbarresyndromefollowingjanssencovid19vaccination
AT podurysanjiti anovelcaseofbifacialdiplegiavariantofguillainbarresyndromefollowingjanssencovid19vaccination
AT tandonmedha anovelcaseofbifacialdiplegiavariantofguillainbarresyndromefollowingjanssencovid19vaccination
AT kingreeseth anovelcaseofbifacialdiplegiavariantofguillainbarresyndromefollowingjanssencovid19vaccination
AT sriwastavashitiz anovelcaseofbifacialdiplegiavariantofguillainbarresyndromefollowingjanssencovid19vaccination
AT prasadapoorv novelcaseofbifacialdiplegiavariantofguillainbarresyndromefollowingjanssencovid19vaccination
AT hurlburtgage novelcaseofbifacialdiplegiavariantofguillainbarresyndromefollowingjanssencovid19vaccination
AT podurysanjiti novelcaseofbifacialdiplegiavariantofguillainbarresyndromefollowingjanssencovid19vaccination
AT tandonmedha novelcaseofbifacialdiplegiavariantofguillainbarresyndromefollowingjanssencovid19vaccination
AT kingreeseth novelcaseofbifacialdiplegiavariantofguillainbarresyndromefollowingjanssencovid19vaccination
AT sriwastavashitiz novelcaseofbifacialdiplegiavariantofguillainbarresyndromefollowingjanssencovid19vaccination